Company Overview of Cellectis Plant Sciences Inc
Cellectis Plant Sciences Inc operates as a subsidiary of Cellectis.
1000 Westgate Drive
St Paul, MN 55114
Key Executives for Cellectis Plant Sciences Inc
Compensation as of Fiscal Year 2014.
Cellectis Plant Sciences Inc Key Developments
Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies
Dec 19 14
Cellectis plant sciences and the Two Blades Foundation (2Blades) announced the execution of a non-exclusive cross-license agreement relating to TAL nuclease technologies. Pursuant to the agreement, 2Blades receives a license to TALEN(TradeMark) technology for not-for-profit uses, including use in 2Blades' humanitarian efforts to support subsistence farming, and for certain commercial applications related to the disease resistance programs of 2Blades. In addition, pursuant to the agreement, Cellectis plant sciences receives a license under 2Blades' TAL Code technology related to nucleases for commercial uses in certain specified crop plants. Cellectis plant sciences has an option to expand its license to additional crops. Financial terms of the agreement were not disclosed.
Cellectis Plant Sciences and Bayer CropScience Extend Partnership to Improve Crops by Gene Editing
Jan 30 14
Cellectis plant sciences has signed two new agreements with Bayer CropScience on gene editing in plants. The agreements extend the companies' existing partnership to introduce targeted modifications to selected plant genes and genomes. The first aim of this extended partnership is to collaboratively create commercial traits for the canola seed market using new technologies developed by Cellectis plant sciences. The second aim is to provide Bayer with access to technologies that enable the directed engineering of plant genomes, such as gene stacking and targeted mutagenesis, for the development of improved crops.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries